ATE230275T1 - Angiogense-inhibitor - Google Patents

Angiogense-inhibitor

Info

Publication number
ATE230275T1
ATE230275T1 AT96116994T AT96116994T ATE230275T1 AT E230275 T1 ATE230275 T1 AT E230275T1 AT 96116994 T AT96116994 T AT 96116994T AT 96116994 T AT96116994 T AT 96116994T AT E230275 T1 ATE230275 T1 AT E230275T1
Authority
AT
Austria
Prior art keywords
angiogensis
inhibitor
angiogensis inhibitor
Prior art date
Application number
AT96116994T
Other languages
English (en)
Inventor
Chiho Fukiage
Mitsuyoshi Azuma
Jun Rui Inoue
Masayuki Nakamura
Yuka Yoshida
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE230275T1 publication Critical patent/ATE230275T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96116994T 1995-10-25 1996-10-23 Angiogense-inhibitor ATE230275T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27748595 1995-10-25
JP24804696 1996-09-19

Publications (1)

Publication Number Publication Date
ATE230275T1 true ATE230275T1 (de) 2003-01-15

Family

ID=26538555

Family Applications (3)

Application Number Title Priority Date Filing Date
AT96116994T ATE230275T1 (de) 1995-10-25 1996-10-23 Angiogense-inhibitor
AT99102501T ATE230389T1 (de) 1995-10-25 1996-10-23 Angiogenese inhibitoren
AT99106760T ATE239698T1 (de) 1995-10-25 1996-10-23 Angiogenese hemmer

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT99102501T ATE230389T1 (de) 1995-10-25 1996-10-23 Angiogenese inhibitoren
AT99106760T ATE239698T1 (de) 1995-10-25 1996-10-23 Angiogenese hemmer

Country Status (13)

Country Link
US (2) US6057290A (de)
EP (2) EP0927716B1 (de)
AR (1) AR004694A1 (de)
AT (3) ATE230275T1 (de)
AU (1) AU716495B2 (de)
BR (1) BR9605267A (de)
CA (1) CA2188817C (de)
DE (3) DE69628050T2 (de)
ES (2) ES2190139T3 (de)
HU (1) HUP9602943A3 (de)
MX (1) MX9605156A (de)
NO (1) NO964514L (de)
PL (1) PL316669A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2226740A1 (en) * 1995-07-13 1997-01-30 Mitsuyoshi Azuma Piperazine derivative and its uses
US6214800B1 (en) * 1995-10-25 2001-04-10 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
JP4336039B2 (ja) * 1997-09-04 2009-09-30 日本ケミファ株式会社 エポキシコハク酸アミド誘導体
US6015787A (en) * 1997-11-04 2000-01-18 New England Medical Center Hospitals, Inc. Cell-permeable protein inhibitors of calpain
BR9908566A (pt) * 1998-03-05 2000-11-21 Senju Pharma Co Composição farmacêutica para profilaxia e terapia de doenças associadas a citopatia do tecido do fundo ocular
US6342531B1 (en) * 1998-03-20 2002-01-29 Senju Pharmaceutical Co., Ltd. Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
GB9819860D0 (en) * 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
CA2356929A1 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia
WO2000058280A1 (en) * 1999-03-26 2000-10-05 Shionogi & Co., Ltd. Carbocyclic sulfonamide derivatives
KR20010001270A (ko) 1999-06-03 2001-01-05 복성해 혈관신생을 억제하는 새로운 이소쿠마린 유도체
WO2001026648A1 (en) 1999-10-13 2001-04-19 Senju Pharmaceutical Co., Ltd. Ophthalmic adhesive preparations for percutaneous absorption
WO2001041757A1 (en) * 1999-12-10 2001-06-14 Senju Pharmaceutical Co., Ltd. Cyclodextrin-containing pharmaceutical composition
EP1334718A4 (de) * 2000-10-26 2007-07-18 Senju Pharma Co Arzneimittelzusammensetzung mit einem dipeptydylaldehydderivat
JPWO2002048096A1 (ja) * 2000-12-12 2004-04-15 千寿製薬株式会社 ヒドラゾン誘導体およびその医薬用途
ATE335722T1 (de) * 2001-06-06 2006-09-15 Lilly Co Eli Benzoylsulfonamide und sulfonylbenzamidine zur verwendung als antitumor-mittel
US7115607B2 (en) * 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
US7202274B2 (en) * 2002-03-15 2007-04-10 Senju Pharmaceutical Co., Ltd. Cyclic hemiacetal derivative and use thereof
DE60333268D1 (de) 2002-03-29 2010-08-19 Senju Pharma Co Hydroxymorpholinonderivat und dessen medizinische verwendung
EP1354586A1 (de) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH Verwendung von Hydroxypyridon Derivaten zur Wundheilung
ATE448198T1 (de) 2002-07-22 2009-11-15 Senju Pharma Co Neue alpha-ketoamidderivate und deren verwendung
GB0314262D0 (en) 2003-06-19 2003-07-23 Univ Nottingham Trent Novel compounds and methods of using the same
US7615556B2 (en) 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
WO2011105070A1 (ja) 2010-02-25 2011-09-01 パナソニック株式会社 需給制御装置、需給制御方法、およびプログラム
CN103052382B (zh) 2010-07-14 2014-10-22 千寿制药株式会社 α-酮酰胺衍生物的固体分散体
GB201218084D0 (en) 2012-10-09 2012-11-21 Univ Aston Novel compounds and methods for use in medicine
GB201220474D0 (en) * 2012-11-14 2012-12-26 Sagetis Biotech Sl Polypeptides
US20210145930A1 (en) * 2018-05-07 2021-05-20 NeuroTheranostics, Inc. Multiple layer article with interactive reinforcements linear ribbon fiber reinforcement for composite forms
WO2022187491A1 (en) * 2021-03-03 2022-09-09 The Texas A& M University System Inhibitors of cysteine proteases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50137951A (de) 1974-04-27 1975-11-01
JPS5754157A (en) 1980-09-19 1982-03-31 Nippon Kayaku Co Ltd L-argininal derivative and its preparation
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
JPH0832698B2 (ja) * 1987-05-08 1996-03-29 日本ケミファ株式会社 ピペラジン誘導体
JP2536754B2 (ja) * 1987-05-08 1996-09-18 日本ケミファ株式会社 ピペラジン誘導体
JP2701932B2 (ja) 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
US5510531A (en) 1989-04-10 1996-04-23 Suntory Limited Proteinase inhibitor
EP0395309B1 (de) * 1989-04-28 1995-12-27 Takara Shuzo Co. Ltd. Dem menschlichen Calpastatin ähnliches Polypeptid
AU1531092A (en) 1991-02-22 1992-09-15 Du Pont Merck Pharmaceutical Company, The Substituted alpha-aminoaldehydes and derivatives
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
CA2071621C (en) * 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
JP2848232B2 (ja) * 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
US5607831A (en) 1993-03-25 1997-03-04 The United States Of America As Represented By The Department Of Health And Human Services In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death
US5658885A (en) 1993-04-27 1997-08-19 The Dupont Merck Pharmaceutical Company Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
JP3599287B2 (ja) * 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
AU3534195A (en) * 1994-09-27 1996-04-19 Takeda Chemical Industries Ltd. Aldehyde derivatives as upsteine protease inhibitors
US5614649A (en) 1994-11-14 1997-03-25 Cephalon, Inc. Multicatalytic protease inhibitors
EP0731107A1 (de) * 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Herstellung von Aldehyd-Derivaten
JPH11505532A (ja) 1995-05-10 1999-05-21 カイロサイエンス・リミテッド 金属プロテアーゼとｔｎｆの放出を抑制するペプチド化合物およびその治療的使用
CA2226740A1 (en) * 1995-07-13 1997-01-30 Mitsuyoshi Azuma Piperazine derivative and its uses
WO1997021690A1 (en) 1995-11-28 1997-06-19 Cephalon, Inc. D-amino acid derived inhibitors of cysteine and serine proteases

Also Published As

Publication number Publication date
DE69625575T2 (de) 2003-09-25
EP0771565B1 (de) 2003-01-02
PL316669A1 (en) 1997-04-28
EP0927716A1 (de) 1999-07-07
CA2188817A1 (en) 1997-04-26
EP0771565A3 (de) 1998-11-04
AU716495B2 (en) 2000-02-24
ATE230389T1 (de) 2003-01-15
EP0771565A2 (de) 1997-05-07
US6551999B1 (en) 2003-04-22
DE69625622T2 (de) 2003-08-14
DE69625575D1 (de) 2003-02-06
AU7038496A (en) 1997-05-01
NO964514D0 (no) 1996-10-24
US6057290A (en) 2000-05-02
BR9605267A (pt) 1998-07-21
DE69628050D1 (de) 2003-06-12
HUP9602943A2 (en) 1997-08-28
ES2193615T3 (es) 2003-11-01
DE69625622D1 (de) 2003-02-06
ATE239698T1 (de) 2003-05-15
AR004694A1 (es) 1999-03-10
MX9605156A (es) 1998-05-31
HUP9602943A3 (en) 1998-03-02
CA2188817C (en) 2010-01-26
EP0927716B1 (de) 2003-05-07
NO964514L (no) 1997-04-28
DE69628050T2 (de) 2004-04-01
ES2190139T3 (es) 2003-07-16

Similar Documents

Publication Publication Date Title
ATE230275T1 (de) Angiogense-inhibitor
NO981938D0 (no) Proteaseinhibitorer
FI963597A7 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI972160A0 (fi) Matriisimetalloproteaasi-inhibiittorit
NO942064D0 (no) yminhibitorer
FI941767A7 (fi) 1H-indoli-3-asetamidi sPLA2 inhibiittoreita
IS4771A (is) Interlevkín-1ß umbreytiensím tálmar
ID19198A (id) Inhibitor metaloprotease heterosiklik
FI951553L (fi) 1H-indoli-glyoksyyliamidi-sPLA2-inhibiittoreita
FI962904L (fi) Metalloproteinaasi-inhibiittoreita
FI962905A7 (fi) Metalloproteinaasi-inhibiittoreita
ID18416A (id) Inhibitor metaloprotease diheterosiklik
PT858464E (pt) Inibidores de trombina
NO974403L (no) Reversible proteasehemmere
FI973282L (fi) Trombiinin inhibiittoreita
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
FI971784L (fi) Apolipoproteiini B-synteesin estäjiä
FI972198L (fi) Metalloproteinaasi-inhibiittoreita
DE69526475D1 (de) 5-Alphareduktase-Inhibitoren
NO980643D0 (no) Propylendopeptidase inhibitorer
PT863916E (pt) Tripeptidos de polifluoroalquil triptofano inibidores de trombina
BR9610514A (pt) Inibidores cicloantihelmínticos
EP1007548A4 (de) Tsetse-thrombin inhibitor
KR970703937A (ko) 금속단백질 분해효소 억제제(Metallproteinase inhibitors)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties